Cited by 357Cervical Cancer and HPV ResearchWomen's cancer prevention and managementEndometrial and Cervical Cancer Treatments

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

The IARC Perspective on Cervical Cancer Screening

Open access

Bouvard, Véronique, Wentzensen, Nicolas, Mackie, Anne, Berkhof, Johannes, Brotherton, Julia, Giorgi-Rossi, Paolo, Kupets, Rachel, Smith, Robert, Arrossi, Silvina, Bendahhou, Karima, Canfell, Karen, Chirenje, Z. Mike, Chung, Michael H., del Pino, Marta, de Sanjosé, Silvia, Elfström, Miriam, Franco, Eduardo L., Hamashima, Chisato, Hamers, Françoise F., Herrington, C. Simon, Murillo, Raúl, Sangrajrang, Suleeporn, Sankaranarayanan, Rengaswamy, Saraiya, Mona, Schiffman, Mark, Zhao, Fanghui, Arbyn, Marc, Prendiville, Walter, Indave Ruiz, Blanca I., Mosquera-Metcalfe, Isabel, Lauby-Secretan, Béatrice·2021·New England Journal of Medicine

DOI 10.1056/nejmsr2030640PMC PMC12125667

Open this paper in CoChat — free account Open PDF

Abstract

In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmsr2030640

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30482-6 · Cited by 4,465
Self-citation
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O. J., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,479
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Self-citation
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278
Self-citation
Estimates of the global burden of cervical cancer associated with HIV
Stelzle, D., Tanaka, L. F., Lee, K. K., Khalil, A. I., Baussano, I., Shah, A. S. V., McAllister, D., Gottlieb, S. L., Klug, S. J., Winkler, A. S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30459-9 · Cited by 1,004
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citation
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Self-citation
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851
Self-citation

Show all 65 references

Research works printed but not linked: 3

Cervix cancer screening. IARC handbooks of cancer prevention. Vol. 10. Lyon France: International Agency for Research on Cancer 2005 (https://publications.iarc.fr/380).
Serrano B Roura E Guijarro P et al. National cervical cancer screening programs and coverage worldwide. Presented at the 33rd International Papillomavirus Conference virtual July 20–24 2020.
Cervical cancer screening. IARC handbooks of cancer prevention. Vol. 18. Lyon France: International Agency for Research on Cancer (in press).

Sorted by citations

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00501-0 · Cited by 1,616
Self-citation
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis
Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., Poljak, M., Murillo, R., Broutet, N., Riley, L. M., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00241-8 · Cited by 558
Self-citation
Cervical Cancer Screening
Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023) · JAMA · doi:10.1001/jama.2023.13174 · Cited by 553
Self-citation
Worldwide use of HPV self-sampling for cervical cancer screening
Serrano, B., Ibáñez, R., Robles, C., Peremiquel‐Trillas, P., de Sanjosé, S., & Bruni, L. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106900 · Cited by 298
IARC Perspective on Oral Cancer Prevention
Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., Chen, T. H.-H., Ayo-Yusuf, O. A., Gupta, P. C., Kerr, A. R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmsr2210097 · Cited by 166
Self-citation
Advances in cervical cancer: current insights and future directions
Xu, M., Cao, C., Wu, P., Huang, X., & Ma, D. (2024) · 癌症：英文版 · doi:10.1002/cac2.12629 · Cited by 180
Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022
Wu, J., Jin, Q., Zhang, Y., Ji, Y., Li, J., Liu, X., Duan, H., Feng, Z., Ya, L., Zhang, Y., et al. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.11.006 · Cited by 193
Dendritic Cells in Cancer Immunology and Immunotherapy
Hato, L., Atienza, Á. V., Eguren‐Santamaría, I., Perez‐Gracia, J. L., Rodríguez, J., Pérez‐Larraya, J. G., Sarobe, P., Inogés, S., de Cerio, A. L. D., & Santisteban, M. (2024) · Cancers · doi:10.3390/cancers16050981 · Cited by 150
Updates on cervical cancer prevention
Viveros-Carreño, D. A., Fernándes, A., & Pareja, R. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003703 · Cited by 131
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105
Self-citation
Cervical cancer screening using DNA methylation triage in a real-world population
Schreiberhuber, L., Barrett, J. J. E., Wang, J., Redl, E., Herzog, C. M. S., Vavourakis, C. D., Sundström, K., Dillner, J., & Widschwendter, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03014-6 · Cited by 114
Cervical cancer: a new era
Caruso, G., Wagar, M. K., Hsu, H., Hoegl, J., Valzacchi, G. M. R., Fernándes, A., Cucinella, G., Aker, S. Ş., Jayraj, A. S., Mauro, J., et al. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005579 · Cited by 78
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines
Massad, L. S., Clarke, M. A., Perkins, R. B., García, F., Chelmow, D. P., Cheung, L. C., Darragh, T. M., Egemen, D., Lorey, T. S., Nayar, R., et al. (2025) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000865 · Cited by 71
Self-citation
Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee
Wentzensen, N., Massad, L. S., Clarke, M. A., Garcia, F. M. P., Smith, R. A., Murphy, J., Guido, R. S., Reyes, A., Phillips, S. M., Berman, N. R., et al. (2025) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000885 · Cited by 62
Self-citation
Cervical Cancer
Sahasrabuddhe, V. V. (2024) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2024.03.005 · Cited by 76
A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma
Zou, J., Lin, Z., Jiao, W., Chen, J., Lin, L., Zhang, F., Zhang, X., & Zhao, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20566-0 · Cited by 59
Artificial intelligence–based image analysis in clinical testing: lessons from cervical cancer screening
Egemen, D., Perkins, R. B., Cheung, L. C., Befano, B., Rodríguez, A. C., Desai, K. T., Lemay, A., Ahmed, S. R., Antani, S., Jerónimo, J., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad202 · Cited by 55
Self-citation
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings
Kundrod, K. A., Barra, M., Wilkinson, A. F., Smith, C. A., Natoli, M. E., Chang, M. M., Coole, J. B., Santhanaraj, A., Lorenzoni, C. F., Mavume, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4768 · Cited by 56
Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county‐level income in the United States, 2000–2019
Amboree, T. L., Damgacioglu, H., Sonawane, K., Adsul, P., Montealegre, J. R., & Deshmukh, A. A. (2024) · International Journal of Cancer · doi:10.1002/ijc.34860 · Cited by 50
Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication
Reza, S., Anjum, R., Khandoker, R. Z., Khan, S. R., Islam, M. R., & Dewan, S. M. R. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101460 · Cited by 54
Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids
Song, H., Jiang, H., Hu, W., Hai, Y., Cai, Y., Li, H., Liao, Y. R., Huang, Y., Lv, X., Zhang, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl3511 · Cited by 49
Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020
Zhang, W., Guo, N., Li, B., Shang, E., Wang, J., Zhang, M., & Yang, X. (2023) · Virology Journal · doi:10.1186/s12985-023-01959-7 · Cited by 48
Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses
Galati, L., Chiantore, M. V., Marinaro, M., & Bonito, P. D. (2024) · Viruses · doi:10.3390/v16030416 · Cited by 56
Cervical Cancer Screening Recommendations: Now and for the Future
Rayner, M., Welp, A. M., Stoler, M. H., & Cantrell, L. A. (2023) · Healthcare · doi:10.3390/healthcare11162273 · Cited by 60
Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update
Shastri, S. S., Temin, S., Almonte, M., Basu, P. S., Campos, N. G., Gravitt, P. E., Gupta, V., Lombe, D. C., Murillo, R., Nakisige, C., et al. (2022) · JCO Global Oncology · doi:10.1200/go.22.00217 · Cited by 46
Self-citation
Strategies to eliminate cervical cancer in China
Ji, L., Chen, M., & Yao, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1105468 · Cited by 46
Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection
Xue, P., Dang, L., Kong, L.-H., Tang, H., Xu, H., Weng, H., Wang, Z., Wei, R., Xu, L., Li, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58883-3 · Cited by 45
Self-citation
Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study
Zhang, W., Gao, K., Fowkes, F. J. I., Adeloye, D., Rudan, I., Song, P., Jin, M., & Chen, K. (2022) · Globalization and Health · doi:10.1186/s12992-022-00890-w · Cited by 41
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions
Arbyn, M., Costa, S., Latsuzbaia, A., Kellen, E., Rossi, P. G., Cocuzza, C. E., Basu, P. S., & Castle, P. E. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1041 · Cited by 41
Self-citation
Cell-free DNA: a promising biomarker in infectious diseases
Hu, Y., Zhao, Y., Zhang, Y., Chen, W., Zhang, H., & Jin, X. K. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.06.005 · Cited by 40
Risk factors for the development of cervical cancer: analysis of the evidence
Luvián‐Morales, J., Gutiérrez-Enríquez, S. O., Granados-García, V., & Torres-Poveda, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1378549 · Cited by 38
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control
Castle, P. E. (2024) · Viruses · doi:10.3390/v16091357 · Cited by 40
Impact of cervical screening by human papillomavirus genotype: Population-based estimations
Wang, J., Elfström, K. M., Lagheden, C., Eklund, C., Sundström, K., Sparén, P., & Dillner, J. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004304 · Cited by 36
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process
Wentzensen, N., García, F., Clarke, M. A., Massad, L. S., Cheung, L. C., Egemen, D., Guido, R. S., Huh, W. K., Saslow, D., Smith, R. A., et al. (2024) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000804 · Cited by 33
Self-citation
An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation
Okunade, K. S., Adejimi, A. A., John‐Olabode, S., Oshodi, Y. A., & Oluwole, A. A. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s296914 · Cited by 36
Cancer screening programs in South-east Asia and Western Pacific
Wee, H. L., Canfell, K., Chiu, H., Choi, K. S., Cox, B., Bhoo‐Pathy, N., Simms, K. T., Hamashima, C., Shen, Q., Chua, B. W. B., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-023-10327-8 · Cited by 32
Self-citation
Detection of endometrial cancer using tampon-based collection and methylated DNA markers
Bakkum-Gamez, J. N., Sherman, M. E., Slettedahl, S. W., Mahoney, D. W., Lemens, M. A., Laughlin-Tommaso, S. K., Hopkins, M. R., VanOosten, A. L., Shridhar, V., Staub, J. K., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.04.014 · Cited by 30
Self-citation
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening
Arbyn, M., Cuschieri, K. S., Bonde, J. H., Schuurman, R., Cocuzza, C. E., Broeck, D. V., Zhao, F., Rezhake, R., Gültekin, M., de Sanjosé, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29881 · Cited by 31
Self-citation
Use of risk-based cervical screening programs in resource-limited settings
Perkins, R. B., Smith, D. L., Jerónimo, J., Campos, N. G., Gage, J. C., Hansen, N., Rodríguez, A. C., Cheung, L. C., Egemen, D., Befano, B., et al. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102369 · Cited by 28
Self-citation
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV
Hall, M. T., Simms, K. T., Murray, J. M., Keane, A., Nguyen, D. T. N., Caruana, M., Lui, G., Kelly, H. A., Eckert, L. O., Santesso, N. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02601-3 · Cited by 30
Self-citation
Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and naïve CD4+ T cells in the immunosuppressive microenvironment of cervical cancer
Chen, H., Ma, R., Zhou, B., Yang, X., Duan, F., & Wang, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107151 · Cited by 27
Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions
Lee, K., Suh, M., & Choi, K. S. (2025) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.25.268 · Cited by 26
Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study
Teixeira, J. C., Vale, D. B., Discacciati, M. G., Campos, C. S., Bragança, J. F., & Zeferino, L. C. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1763493 · Cited by 25
Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019
Abila, D. B., Wasukira, S. B., Ainembabazi, P., Nakiyingi, E. K., Chemutai, B., Kyagulanyi, E., Varsani, J. V., Shindodi, B., Kisuza, R. K., & Niyonzima, N. (2024) · JCO Global Oncology · doi:10.1200/go.23.00385 · Cited by 28
Addressing global disparities in cervical cancer burden: a narrative review of emerging strategies
Gopalkrishnan, K., & Karim, R. (2025) · Current HIV/AIDS Reports · doi:10.1007/s11904-025-00727-2 · Cited by 24
Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey
Znaor, A., Ryzhov, A., Losada, M. L., Carvalho, A. L., Smelov, V., Барчук, А. А., Valkov, М. Y., Ten, E., Andreasyan, D., Zhizhilashvili, S., et al. (2023) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2023.100436 · Cited by 23
Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action
Boldeanu, L., Assani, M.-Z., Boldeanu, M. V., Siloşi, I., Manolea, M. M., Văduva, C.-C., Assani, A.-D., & Dijmărescu, A. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178463 · Cited by 23
State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI
Engels, E. A., Shiels, M. S., Barnabas, R. V., Bohlius, J., Brennan, P., Castilho, J. L., Chanock, S. J., Clarke, M. A., Coghill, A. E., Combes, J., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34727 · Cited by 29
Trop-2 expression and the tumor immune microenvironment in cervical cancer
Chiba, Y., Kojima, Y., Yazaki, S., Yoshida, H., Takamizawa, S., Kitadai, R., Saito, A., Okuma, H. S., Nishikawa, T., Shimoi, T., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.04.022 · Cited by 23
Population-Based Trends in Cervical Cancer Incidence and Mortality in Brazil: Focusing on Black and Indigenous Population Disparities
de Melo, A. C., da Silva, J. L., dos Santos, A. L. S., & Thuler, L. C. S. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01516-6 · Cited by 22
SlipChip Enables the Integration of CRISPR-Cas12a and RPA for Fast and Stand-Alone HPV Detection
Zhao, Y., Li, Z., Li, T., Rao, R., Zhu, J., Hu, R., Xu, G., Li, Y., & Yang, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05290 · Cited by 21
HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications
Zhang, Y., Fan, Z., Wang, J., Guan, B., Zhou, F., Tang, Z., Wu, W., & Huang, A. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03841-w · Cited by 27
Dual-enzyme cascade amplification electrochemical biosensor for human papillomavirus based on DNA nanoflower structure
He, H., Cheng, L., He, Y., Chen, J., Song, L., Yang, Y., Zhang, Y., Lin, Z., & Hong, G. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132532 · Cited by 20
A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
Nickson, C., Smith, M. A., Feletto, E., Velentzis, L. S., Broun, K., Deij, S., Grogan, P. B., Hall, M. T., He, E., John, D. J. S., et al. (2023) · eLife · doi:10.7554/elife.82818 · Cited by 20
Self-citation
Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
Mallafré‐Larrosa, M., Ritchie, D., Papi, G., Mosquera, I., Mensah, K., Lucas, E., Bøje, R. B., Kirkegaard, P., Andersen, B. S., Basu, P. S., et al. (2023) · European Journal of Public Health · doi:10.1093/eurpub/ckad055 · Cited by 20
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study
Benevolo, M., Ronco, G., Mancuso, P., Carozzi, F., De Marco, L., Allia, E., Bisanzi, S., Rizzolo, R., Gustinucci, D., Del Mistro, A., et al. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105149 · Cited by 19
Self-citation
No woman left behind: achieving cervical cancer elimination among women living with HIV
Sharma, K., Machalek, D. A., Toh, Z. Q., Amenu, D., Muchengeti, M. M., Ndlovu, A. K., Mremi, A., Mchome, B. L., Vallely, A. J., Denny, L. E., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(23)00082-6 · Cited by 19
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination
El‐Zein, M., & Franco, E. L. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2486653 · Cited by 19
Self-citation
Development of a multimodal mobile colposcope for real-time cervical cancer detection
Coole, J. B., Brenes, D., Resende, J. C. P., Antoniazzi, M., Fonseca, B. D. O., Maker, Y. N., Kortum, A., Vohra, I. S., Schwarz, R. A., Carns, J., et al. (2022) · Biomedical Optics Express · doi:10.1364/boe.463253 · Cited by 18
Cervical cancer elimination in Indian context: Moving from barriers to facilitators
Vikraman, S. M., Khanna, D., & Dandpat, A. (2022) · Cancer · doi:10.1002/cncr.34486 · Cited by 18
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework
Latsuzbaia, A., Broeck, D. V., Keer, S. V., Weyers, S., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Sutter, P. D., Vorsters, A., & Arbyn, M. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.06.004 · Cited by 21
Self-citation
Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy
Gazzetta, S., Valent, F., Sala, A., Driul, L., & Brunelli, L. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1336250 · Cited by 18
Transition from opportunistic cytological to organized screening program with DNA-HPV testing detected prevalent cervical cancers 10 years in advance
Teixeira, J. C., Vale, D. B., Campos, C. S., Polegatto, I., Bragança, J. F., Discacciati, M. G., & Zeferino, L. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-71735-2 · Cited by 21
Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study
Dong, B., Lü, Z., Yang, T., Wang, J., Zhang, Y., Tuo, X., Wang, J., Lin, S., Cai, H., Huan, C., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101480 · Cited by 20
Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020
de la Cruz, S. P., & Cebrino, J. (2022) · Cancers · doi:10.3390/cancers14102481 · Cited by 17
HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia
Davies, P. O., Алулоски, И., Aluloski, D., Brcanski, J., Davidzenka, A., Durdyeva, A., Umarzoda, S. G., Goshliyev, K., Jovanović, V., Jugeli, L., et al. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.5.1781 · Cited by 20
Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis
Kim, S., An, H., Cho, H., Min, K., Hong, J. H., Lee, S., Song, J. Y., Lee, J. K., & Lee, N. W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124024 · Cited by 17
Predicting cervical cancer risk probabilities using advanced H20 AutoML and local interpretable model-agnostic explanation techniques
Prusty, S., Patnaik, S., Dash, S. K., Prusty, S. G. P., Rautaray, J., & Sahoo, G. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.1916 · Cited by 17
Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales
Tatar, O., Haward, B., Zhu, P., Griffin-Mathieu, G., Perez, S., McBride, E., Lofters, A., Smith, L., Mayrand, M., Daley, E. M., et al. (2023) · Current Oncology · doi:10.3390/curroncol30010093 · Cited by 16
Self-citation
Correlation analysis of vaginal microecology and different types of human papillomavirus infection: a study conducted at a hospital in northwest China
Feng, F., Hou, Y.-M., Zhang, Y., Wang, L., Li, P.-P., Guo, Y. C., & An, R. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1138507 · Cited by 16
Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia
Gari, A. M., Ghazzawi, M. A., Ghazzawi, S. A., Alharthi, S. M., Yanksar, E. A., Almontashri, R. M., Batarfi, R., Kinkar, L. I., & Baradwan, S. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100361 · Cited by 16
Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort
Gilham, C., Nedjai, B., Scibior‐Bentkowska, D., Reuter, C., Banwait, R., Brentnall, A. R., Cuzick, J. M., Peto, J., & Lörincz, A. T. (2024) · International Journal of Cancer · doi:10.1002/ijc.34913 · Cited by 16
Cancer Screening Companies Are Rapidly Proliferating: Are They Ready for Business?
Fernandez-Uriarte, A., Pons-Belda, O. D., & Diamandis, E. P. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0102 · Cited by 17
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Zigras, T., Mayrand, M., Bouchard, C., Salvador, S., Eiriksson, L. R., Almadin, C., Kean, S., Dean, E. A., Malhotra, U., Todd, N. J., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060425 · Cited by 15
Long‐term follow‐up of cervical cancer incidence after normal cytological findings
Wang, J., Edvardsson, H., Strander, B., Andrae, B., Sparén, P., & Dillner, J. (2023) · International Journal of Cancer · doi:10.1002/ijc.34723 · Cited by 14
Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs
Qi, M., Naranjo, A. R., Duque, A. J., Lorey, T. S., Schapiro, J. M., Suh-Burgmann, B. J., Rummel, M., Salipante, S. J., Wentzensen, N., & Greene, D. N. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.02.006 · Cited by 15
Self-citation
Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection
Chen, Z., Lin, H., Zheng, J., Cai, L., Chen, Z., Li, J., & Yu, L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07893-3 · Cited by 18
The IARC Perspective on Cervical Cancer Screening
Suba, E. J., Ortega, R. E., & Mutch, D. G. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2119177 · Cited by 15
Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women
Jing, F., Zhai, L., Wang, J., Zhu, X., Liu, P., Wang, L., Ma, D., Li, L., & Zhou, J. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01804-w · Cited by 14
Harnessing Aggregation‐Induced Emission‐Based Detection Toolbox for Diagnostics of Urogenital Tumors
Chen, W., Guan, H., Lu, Y., Zeng, G., Gu, D., Guo, K., Jiang, C., & Liu, H. (2025) · Aggregate · doi:10.1002/agt2.70008 · Cited by 15
Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: a systematic review
Chakravarti, P., Maheshwari, A., Tahlan, S., Kadam, P. R., Bagal, S. S., Gore, S., Panse, N. S., Deodhar, K., Chaturvedi, P., Dikshit, R. P., et al. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1427 · Cited by 15
Unsupervised Domain Adaptive Dose Prediction via Cross-Attention Transformer and Target-Specific Knowledge Preservation
Cui, J., Xiao, J., Hou, Y. F., Xi, W., Zhou, J., Peng, X., & Wang, Y. (2023) · International Journal of Neural Systems · doi:10.1142/s0129065723500570 · Cited by 14
Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative
Nayar, R. (2023) · Cancer Cytopathology · doi:10.1002/cncy.22733 · Cited by 13
Cervical cancer in Thailand: 2023 update
Wongpratate, M., & Bumrungthai, S. (2024) · Obstetrics & Gynecology Science · doi:10.5468/ogs.23277 · Cited by 13
The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets
Brotherton, J. M. L., Vajdic, C. M., & Nightingale, C. E. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2451732 · Cited by 14
Self-citation
Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities
Cruz-Valdéz, A., Palacio-Mejía, L. S., Quezada-Sanchez, A. D., Hernández‐Ávila, J. E., Galicia-Carmona, T., Cetina, L., Arango-Bravo, E. A., Isla‐Ortiz, D., Aranda-Flores, C. E., Uscanga-Sánchez, S., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1008560 · Cited by 13
Analyzing and forecasting global cervical cancer burden based on WHO’s elimination strategy: insights and projections from a 1990–2021 global burden of disease (GBD) study covering 204 countries and territories
Huang, Y., Lin, W., Chen, X., Zheng, X., Yi, H., & Zhang, L. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.038 · Cited by 15
Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review
Dartibale, C. B., Prado, G. D. C., Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., Morelli, F., Souza, R. P., Group PREVENT YOURSELF, da Silva, V. R. S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.948471 · Cited by 14
Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium
Polverini, P. J., Nör, F., & Nor, J. E. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2022.1095842 · Cited by 13
The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique
Salcedo, M. P., Lathrop, E., Osman, N. B., Neves, A., Rangeiro, R., Mariano, A. A. N., Nkundabatware, J. C., Tivir, G., Carrilho, C., Monteiro, E. C. S., et al. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004958 · Cited by 13
Screening Methods for Cervical Cancer
Li, J., Adobo, S. D., Shi, H., Judicael, K. A. W., Lin, N., & Gao, L. (2024) · ChemMedChem · doi:10.1002/cmdc.202400021 · Cited by 12
Triage performance of DNA methylation for women with high-risk human papillomavirus infection
Kong, L., Xiao, X., Wu, H., You, Y., Jin, X., Liou, Y., Liu, P., Lang, J., & Li, L. (2024) · The Oncologist · doi:10.1093/oncolo/oyae324 · Cited by 12
Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines
Ulhe, A., Raina, P., Chaudhary, A., & Kaul-Ghanekar, R. (2025) · Epigenetics · doi:10.1080/15592294.2025.2451551 · Cited by 14
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
Herzog, C. M. S., Sundström, K., Jones, A., Evans, I., Barrett, J. J. E., Wang, J., Redl, E., Schreiberhuber, L., Costas, L., Paytubi, S., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01353-0 · Cited by 12
The time has come to implement primary human papillomavirus screening for cervical cancer in the United States
Franco, E. L., & American Cancer Society's Primary HPV Screening Initiative (2023) · Cancer · doi:10.1002/cncr.34899 · Cited by 12
Self-citation
Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services
Hall, M. T., Hyatt, A., Smith, M. A., Torode, J., Costa, T., Nguyen, D., Balshaw, T., Grogan, P. B., Sweeny, K., Auste, C., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101423 · Cited by 13
Self-citation
Pricing of HPV tests in Italian tender-based settings
Inturrisi, F., & Berkhof, J. H. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2082777 · Cited by 13
Self-citation
Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its self-efficacy in postoperative patients with cervical cancer
Li, X., Liu, L., He, J., Yan, J., & Wang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1118794 · Cited by 11
The association of cervical cancer screening and quality of care: A systematic analysis of the Global Burden of Disease Study 2019
Wang, M., Jin, Y., & Zheng, Z. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04090 · Cited by 11
Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
Godoy, L. R., Resende, J. C. P., Guimarães, Y. M., Pedrão, P. G., dos Reis, R., & Longatto‐Filho, A. (2022) · Cancers · doi:10.3390/cancers14112612 · Cited by 14

Authors: Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., Kupets, R., Smith, R., Arrossi, S., Bendahhou, K., Canfell, K., Chirenje, Z. M., Chung, M. H., del Pino, M., de Sanjosé, S., Elfström, M., Franco, E. L., Hamashima, C., Hamers, F. F., Herrington, C. S., Murillo, R., Sangrajrang, S., Sankaranarayanan, R., Saraiya, M., Schiffman, M., Zhao, F., Arbyn, M., Prendiville, W., Indave Ruiz, B. I., Mosquera-Metcalfe, I., & Lauby-Secretan, B.
Affiliations: The University of Sydney (AU)
From the International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.M., B.L.-S.), and the National Public Health Agency, Saint-Maurice (F.F.H.) — both in France; the National Cancer Institute, Rockville, MD (N.W., M. Schiffman); Public Health England and Screening, London (A.M.); Amsterdam University Medical Centers, Amsterdam (J. Berkhof); VCS Foundation, Melbourne, VIC (J. Brotherton), Australia; Azienda Unità Sanitaria Locale — IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.R.); the University of Toronto, Toronto (R.K.); the American Cancer Society (R. Smith), Emory University (M.H.C.), and the Centers for Disease Control and Prevention (M. Saraiya) — all in Atlanta; the Center for the Study of the State and Society, and the National Scientific and Technical Research Council — both in Buenos Aires (S.A.); the Casablanca Cancer Registry, Casablanca, Morocco (K.B.); The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King’s Cross, NSW, Austra...
ORCID: Wentzensen, Nicolas
Berkhof, Johannes
Brotherton, Julia
Arrossi, Silvina
Chirenje, Z. Mike
Herrington, C. Simon
Murillo, Raúl
Sankaranarayanan, Rengaswamy
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2021-11-11
Volume: 385
Issue: 20
Pages: 1908-1918
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmsr2030640
PMC: PMC12125667
OpenAlex: W3213089363
Cited by: 357
References: 65
Citations by year: 2026: 63 · 2025: 86 · 2024: 98 · 2023: 77 · 2022: 32 · 2021: 1
FWCI: 37.47
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
PubMed Central (acceptedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Institutional Repositories DataBase (IRDB) (submittedVersion)
Minerva Access (University of Melbourne) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: World Health Organization
National Institutes of Health
Japan Society for the Promotion of Science (20K10331)
National Cancer Institute (ZIACP010124)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords: cervical cancer screening, cervical cancer elimination, screening effectiveness, HPV vaccination, WHO guidelines, cervical cancer prevention, cervical cancer treatment
MeSH terms: Uterine Cervical Neoplasms, Female, Humans, Mass Screening, World Health Organization, Practice Guidelines as Topic, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The IARC Perspective on Cervical Cancer Screening

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks